Q2 2017 Holdings
Filed 2017-08-14 | 145 holdings | $4.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr S&P 500 ETF TRPut | PUT | 78462F953 | $85 | 1,050 | 0.0% |
| Vanguard World FDS(VAW) | MATERIALS ETF | 92204A801 | $143 | 1,175 | 0.0% |
| Fidelity(FHLC) | MSCI HLTH CARE I | 316092600 | $147 | 3,829 | 0.0% |
| Proshares TR(UPW) | PSHS ULTRA UTIL | 74347R685 | $257 | 5,713 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | COM | 481116101 | $259 | 18,442 | 0.0% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $264 | 17,185 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $269 | 26,759 | 0.0% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $275 | 31,057 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $280 | 21,407 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $281 | 2,675 | 0.0% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $291 | 17,691 | 0.0% |
| Tetraphase Pharmaceuticals I | COM | 88165N105 | $292 | 40,885 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $293 | 16,761 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $294 | 10,761 | 0.0% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $294 | 32,504 | 0.0% |
| Inovio Pharmaceuticals Inc | COM NEW | 45773H201 | $294 | 37,461 | 0.0% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $294 | 26,312 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $297 | 5,494 | 0.0% |
| Axovant Sciences LTD | COM | G0750W104 | $298 | 12,857 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $300 | 9,963 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $302 | 4,855 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $303 | 9,973 | 0.0% |
| Aquinox Pharmaceuticals Inc | COM | 03842B101 | $305 | 21,686 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $305 | 14,429 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $306 | 3,846 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $310 | 15,691 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $313 | 114,825 | 0.0% |
| Celldex Therapeutics Inc New | COM | 15117B103 | $314 | 126,989 | 0.0% |
| Calithera Biosciences Inc(CALAEUR) | COM | 13089P101 | $315 | 21,180 | 0.0% |
| Geron Corp(GERN) | COM | 374163103 | $316 | 113,952 | 0.0% |
| Versartis Inc | COM | 92529L102 | $317 | 18,163 | 0.0% |
| Aduro Biotech Inc(ADROEUR) | COM | 00739L101 | $318 | 27,878 | 0.0% |
| Corbus Pharmaceuticals Hldgs(CRBPEUR) | COM | 21833P103 | $320 | 50,795 | 0.0% |
| LA Jolla Pharmaceutical Co(LJPC) | COM PAR $.0001 2 | 503459604 | $320 | 10,761 | 0.0% |
| Loxo Oncology Inc | COM | 548862101 | $321 | 4,009 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $321 | 38,373 | 0.0% |
| Novavax Inc | COM | 670002104 | $322 | 280,087 | 0.0% |
| Paratek Pharmaceuticals Inc | COM | 699374302 | $322 | 13,379 | 0.0% |
| Achillion Pharmaceuticals in(ACHNEUR) | COM | 00448Q201 | $323 | 70,350 | 0.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $324 | 18,896 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $327 | 17,818 | 0.0% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $329 | 3,767 | 0.0% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $331 | 29,324 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $331 | 10,246 | 0.0% |
| Spark Therapeutics Inc | COM | 84652J103 | $332 | 5,552 | 0.0% |
| Ziopharm Oncology Inc | COM | 98973P101 | $333 | 53,612 | 0.0% |
| Aimmune Therapeutics Inc(AIMT) | COM | 00900T107 | $334 | 16,261 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $336 | 85,872 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $343 | 38,871 | 0.0% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $345 | 27,801 | 0.0% |